Intervacc is trading 5.5% down at €0.09 following a weak session for biotech and growth stocks.
- The move appears to be sentiment-driven, with no new company-specific news or filings reported to explain the price action.
- The decline is consistent with a 3% drop in the broader biotech sector ETF and an overall risk-off tone across equity markets.